OrganiGram Holdings Inc. (TSXV:OGI)(OTCQB:OGRMF) (“OrganiGram” or the “Company”) is pleased to announce that it has been chosen as the exclusive Canadian cannabis producer, business partner and brand developer for Nova Scotia-based Trailer Park Boys (“TPB”).
As part of the agreement, OrganiGram will work with the team at TPB Productions Ltd. to develop branding, packaging, and a competitive product portfolio targeted towards recreational marijuana consumers and distributed exclusively by OrganiGram. The deal also includes product placement opportunities as well as branding of peripheral cannabis items.
“This relationship solidifies one of our strategic building blocks as we plan for the legalization of recreational use in Canada. The team at Trailer Park Boys have an aligned vision to develop a National brand with our assistance and we’re incredibly excited at how the partnership will come to life,” said Ray Gracewood, Chief Commercial Officer at OrganiGram.
Trailer Park Boys have become a well-known name within the Canadian entertainment landscape since first appearing on air 1999. Following their agreement with Netflix in 2014, TPB audiences have expanded exponentially into the United States and beyond.
“We remain firmly committed to producing and supplying world-class cannabis for our increasing patient base; and we plan on maintaining that commitment in the future at OrganiGram. But we also need to be strategic about the opportunities that will be afforded to us with the advent of recreational use in Canada. Brands will play a key role within the cannabis market space, and we’re devoting the thought leadership and developing our strategy well in advance of these expected changes to ensure we’re prepared,” added Gracewood.
“We had been monitoring closely to best understand how we might be able to enter the cannabis space in Canada. After our initial meeting with the Maritime based executive team at OrganiGram, we all felt strongly that they were the perfect partner and the timing was right to move forward,” said Louis Thomas, President of Sonic Entertainment Group, representing TPB Productions Limited in this transaction.
The agreement, which has an initial term of five years, encompasses an exclusive product and branding partnership in Canada in exchange for consideration that includes a combination of cash royalties and other non-monetary consideration.
About TPB Productions Limited
TPB Productions is a Nova Scotia based company indirectly controlled by actors Mike Smith, John Paul Tremblay and Robb Wells. The company owns and manages all intellectual property rights associated with Trailer Park Boys, including Canadian and international trademarks, copyrights and music publishing assets.
About OrganiGram Holdings Inc.
OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. OrganiGram’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors – including the availability of funds, the results of financing efforts, crop yields – that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
OrganiGram Holdings Inc.
Giselle Doiron
Director of Investor and Media Relations
(506) 801-8986OrganiGram Holdings Inc.
Ray Gracewood
Chief Commercial Officer
(506) 804-2547

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less